For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Roche's Enicepatide Drug Achieves 15.5% Weight Loss and Blood Sugar Control in Trial

Sep 29, 2026
Roche's Enicepatide Drug Achieves 15.5% Weight Loss and Blood Sugar Control in Trial

Swiss pharmaceutical company Roche has revealed that its experimental obesity drug, enicepatide, has shown significant results in a mid-stage clinical trial involving overweight or obese patients with type 2 diabetes. Participants achieved an average body weight reduction of 15.5%, alongside notable decreases in blood sugar levels. These findings suggest that enicepatide may play a crucial role in managing obesity and diabetes, addressing two major health concerns simultaneously.

Enicepatide functions as a once-weekly injection that mimics two hormones, GLP-1 and GIP, which are instrumental in reducing appetite and regulating blood sugar levels. This dual-action mechanism is central to its effectiveness, allowing it to target metabolic pathways that are critical for weight management and glycemic control.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

In the trial, patients receiving the highest tested dose of 24 milligrams of enicepatide demonstrated significant reductions in HbA1c levels after 48 weeks, meeting the primary endpoints of the study. HbA1c is a key clinical measure that reflects average blood glucose levels over time. Remarkably, around 62% of participants achieved HbA1c levels below 5.7%, indicating that their blood sugar readings fell into the non-diabetic range, according to Roche's data.

The study involved 447 participants, with a small percentage (approximately 2%) discontinuing treatment due to side effects, which were primarily mild to moderate gastrointestinal issues common in this class of medications. Notably, no patients in the placebo group reported similar side effects.

Earlier data from a separate mid-stage trial indicated even stronger results for enicepatide among overweight or obese individuals without type 2 diabetes, with an average weight loss of 22.7%. This reinforces the potential of enicepatide across various patient demographics.

As Roche continues to invest in next-generation treatments, the obesity drug market is projected to exceed $100 billion annually within the next decade, highlighting the significant commercial opportunity in addressing obesity and metabolic diseases. Roche plans to initiate late-stage trials focusing on glycemic control and cardiovascular outcomes in the first half of 2027, which will be critical to advancing enicepatide through regulatory processes and establishing its broader clinical profile.

The progress of enicepatide reflects Roche's ambition to strengthen its position in the obesity treatment landscape, as the demand for effective long-term weight management therapies continues to rise.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)